SHAWNTAE ROMANELLO: Open Payments
NPI 1922531631 · HAMILTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,066 in 162 payments from 14 companies in 2025. Trend: 2023 $2,194 · 2024 $2,287 · 2025 $3,066
Food & beverage: $3,059Education: $8
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 32 | $613 |
| Janssen Pharmaceuticals, Inc | 17 | $492 |
| Alkermes, Inc. | 23 | $438 |
| E.R. Squibb & Sons, L.L.C. | 28 | $289 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $250 |
| Teva Pharmaceuticals USA, Inc. | 13 | $223 |
| Vanda Pharmaceuticals Inc. | 7 | $211 |
| Axsome Therapeutics, Inc. | 3 | $171 |
| Neurocrine BioSciences, Inc. | 6 | $122 |
| Lundbeck LLC | 6 | $110 |
Products named: INVEGA SUSTENNA, REXULTI, ABILIFY MAINTENA, COBENFY, CAPLYTA, LYBALVI, HETLIOZ, ARISTADA.
Industry payments across OH — which companies pay providers there.
